Europe
On Tuesday, the U.K. pharma giant optioned to license an antisense treatment from Ionis Pharmaceuticals following positive Phase II results in chronic hepatitis B virus infection.
Breztri Aerosphere is a triple combination drug of budesonide, glycopyrronium and formoterol fumarate.
Velabs Therapeutics announced that its cooperation with Chiome Bioscience, Inc., Tokyo, will be deepened, to jointly discover modulatory and functional antibodies for one of Chiome’s GPCR target genes.
Pharmaceutical manufacturing license and GMP compliance of the Rentschler Fill Solutions plant reconfirmed by the Austrian Agency for Health and Food Safety (AGES)
Vaccitech announced that it has appointed Bill Enright as its new Chief Executive Officer.
The information contained within this announcement is deemed by the Company to constitute inside information under the Market Abuse Regulation (EU) No. 596/2014
Santhera Pharmaceuticals announces publication by ReveraGen of positive study data with vamorolone in patients with Duchenne muscular dystrophy.
For the third time, the leading international Life-Science company Eppendorf AG hosts the Stem Cell Community Day, which will take place on November 21, 2019 in Lisbon.
Adocia announced that the American Arbitration Association Tribunal governing Adocia’s arbitration claims against Eli Lilly & Company dismissed both parties’ claims in the second and final phase of the arbitration between Adocia and Lilly.
Eli Lilly won an arbitration hearing over accusations the Indianapolis-based company misused confidential information regarding the intellectual property of its former business partner, France-based Adocia S.A.
PRESS RELEASES